Parry-Romberg syndrome is a rare condition in which the skin, fat, muscle, and sometimes bone on one side of the face slowly shrink and waste away. It typically appears during childhood or adolescence, with an average onset around age 13, and progresses over several years before stabilizing. The condition affects women roughly three times more often than men, and in the vast majority of cases, only one side of the face is involved. Bilateral cases occur in just 2% to 7% of people diagnosed.
What Happens to the Face
The hallmark of Parry-Romberg syndrome is progressive hemifacial atrophy, meaning the tissues on one side of the face gradually lose volume. This typically begins with changes in skin color or texture, then deepens as the fat layer beneath the skin thins out. Over time, the underlying muscle can shrink too, and in more severe cases, even the bone structure of the jaw, cheek, or eye socket is affected.
The result is a visible asymmetry between the two sides of the face. The affected side may appear sunken or hollow. Hair loss can occur on the scalp above the affected area, and the skin there may become discolored or develop a tight, shiny appearance. Some people also notice changes in hair or skin pigmentation, similar to what’s seen in vitiligo.
What Causes It
The exact cause remains uncertain, but the most widely accepted theory is that Parry-Romberg syndrome is an autoimmune disorder. It shares significant overlap with a skin condition called linear morphea (localized scleroderma), in which the immune system attacks healthy connective tissue and causes hardening and shrinkage. People with Parry-Romberg syndrome sometimes test positive for antinuclear antibodies, the same immune markers found in lupus and other autoimmune diseases. Some individuals also develop other autoimmune conditions, including rheumatoid arthritis, thyroid disorders, or inflammatory bowel disease.
Several other theories exist. One proposes that inflammation around the sympathetic nerves in the neck disrupts the nerve signals that maintain facial tissue health. Evidence for this comes from cases where surgically interrupting those nerve pathways appeared to halt disease progression. Another theory points to inflammation of small blood vessels in the brain and face, a process similar to what’s seen in certain types of encephalitis. Still others suggest a problem with the migration of neural crest cells, the embryonic cells responsible for building much of the face and skull. In reality, the condition may involve a combination of these mechanisms.
Neurological Effects
Parry-Romberg syndrome is not limited to the face. A significant number of people develop neurological symptoms, and brain imaging often reveals abnormalities on the same side as the facial atrophy. Common findings on MRI include bright spots in the white matter, thickening of the brain’s surface lining, and reduced blood flow to affected areas. Some patients also develop intracranial calcifications or mild brain atrophy.
Epilepsy is one of the more serious complications, occurring in roughly 11% to 20% of patients depending on the study. Seizure onset typically happens around age 13, and the most common type is a focal seizure that spreads to become a full tonic-clonic (convulsive) seizure. About 56% of those with epilepsy experience more than one type of seizure. The good news is that nearly 90% of patients with Parry-Romberg-related epilepsy achieve seizure control with medication. Chronic facial pain and trigeminal neuralgia, a sharp, shock-like pain along the main sensory nerve of the face, are also frequently reported. Headaches and migraines are common as well.
Eye and Dental Involvement
Eye problems show up in 10% to 40% of cases. The most common is enophthalmos, where the eye on the affected side appears sunken because the fat cushion behind it has shrunk. Some people develop inflammation inside the eye (uveitis or iridocyclitis), which can cause redness, pain, light sensitivity, and blurred vision. Other findings include changes in the iris, abnormal patterns in the retinal pigment, and thickening of the muscles that move the eye.
On the dental side, the jaw on the affected side may be smaller or underdeveloped. Tooth roots can be shortened or malformed, and teeth may erupt late or not at all. These changes are most pronounced when the condition begins in early childhood, before the jaw has finished growing.
How It’s Diagnosed
There is no single blood test or definitive marker for Parry-Romberg syndrome. Diagnosis is primarily clinical, based on the characteristic pattern of progressive one-sided facial wasting. MRI and CT scans play an important supporting role, both to assess the extent of facial tissue loss and to check for brain involvement. Typical MRI findings include bright signals in the white matter on the affected side, enhancement of the brain’s surface membranes, and sometimes areas of reduced blood flow or calcification.
The condition most easily confused with Parry-Romberg syndrome is linear scleroderma en coup de sabre, which causes a stripe-like band of hardened, shiny skin across the forehead and scalp. Many experts now consider these two conditions to be part of the same spectrum. The key distinction is that linear scleroderma primarily affects the skin surface with visible sclerotic plaques, while Parry-Romberg syndrome causes deeper tissue loss affecting fat, muscle, and bone. In practice, the two frequently overlap, and some patients show features of both.
The Active Phase and What Comes After
Parry-Romberg syndrome goes through an active phase during which the facial wasting progresses, followed by a period of stabilization where the atrophy stops advancing. The active phase varies widely, lasting anywhere from 2 to 20 years. Once the disease “burns out,” the facial asymmetry remains but does not continue to worsen. This distinction matters because treatment strategies differ depending on whether the disease is still active or has stabilized.
Treatment During Active Disease
While the condition is still progressing, the goal is to slow or halt the immune-driven tissue destruction. Doctors typically use immunosuppressive medications, the same types used for other autoimmune conditions. These work by calming the overactive immune response that’s believed to drive the atrophy. Treatment often continues for months or years, with regular monitoring for side effects. The specific medications and duration vary based on how aggressively the disease is progressing and how the patient responds.
Reconstructive Surgery After Stabilization
Once the active phase has ended and the face is no longer changing, reconstructive surgery can restore facial symmetry. The approach depends on the severity and location of the tissue loss.
For mild volume deficits in any area of the face, fat grafting is usually sufficient. In this procedure, fat is harvested from elsewhere on the body and carefully injected into the hollowed areas. This works well for subtle contour irregularities and can be repeated if needed.
For moderate to severe deficits, particularly in the midface or lower face, a more substantial approach is needed. Surgeons often use what’s called a buried free flap, where a block of tissue (including fat and its blood supply) is transferred from another part of the body, typically the back near the shoulder blade. The tissue from this area offers a good volume of soft tissue, a reliable blood supply, and leaves a relatively inconspicuous donor scar.
Regardless of the primary procedure, follow-up touch-ups are common, usually involving additional fat grafting to smooth contour irregularities. For adolescents, the process is more complex because the face is still growing. Young patients often need monitoring into adulthood and may require multiple revisions as their facial structure matures. The decision to undergo revision surgery ultimately comes down to the patient’s own assessment of the remaining asymmetry.